Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002415:Cats; D004298:Dopamine / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D008297:Male; D008771:Nordefrin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects* / Q000502:physiology; D013154:Spleen / Q000187:drug effects; D013469:Sulpiride / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D013469:Sulpiride; D001058:Apomorphine; D008771:Nordefrin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine